ghk-cu/bpc-157/tb-500 blend dosage chart | GHK-Cu, BPC-157, TB-500 GLOW Peptide Guide: BPC-157 +
Description
In occlusion/occlusion-like syndromes affecting both periphery and brain (portal hypertension, caval hypertension, intracranial hypertension), BPC-157 simultaneously normalized blood pressure disturbances, healed gastrointestinal and liver lesions, minimized brain lesions and hemorrhage, prevented thrombosis, and preserved neurological function
Oral bioavailability of peptides is notoriously low due to enzymatic degradation in the GI tract
For example, FGF studies in 1990s (Damien et al., 1993
Recommended Gauge: 25G - 31G Recommended Length: 3/8" - 5/8" Why These Specifications
The cautious approach: Until more research exists, individuals with active cancer, cancer history, or genetic predisposition should avoid BPC-157
